[go: up one dir, main page]

EP0362350A1 - Procede de production d'heteroaromates azotes a 5 membres - Google Patents

Procede de production d'heteroaromates azotes a 5 membres

Info

Publication number
EP0362350A1
EP0362350A1 EP89904057A EP89904057A EP0362350A1 EP 0362350 A1 EP0362350 A1 EP 0362350A1 EP 89904057 A EP89904057 A EP 89904057A EP 89904057 A EP89904057 A EP 89904057A EP 0362350 A1 EP0362350 A1 EP 0362350A1
Authority
EP
European Patent Office
Prior art keywords
formula
atoms
carboxylic acid
compounds
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP89904057A
Other languages
German (de)
English (en)
Inventor
Richard Kirchlechner
Michael Casutt
Arno Basedow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP0362350A1 publication Critical patent/EP0362350A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the invention relates to a process for the preparation of compounds of formula I.
  • X 1 and X2 each independently of one another • CO-OR2, CO-NR3R4 or CN,
  • R 1 and R2 are each independently hydrogen
  • R 3 and R4 are each independently of one another alkyl with 1-7
  • R and X have the meaning given in the synthesis of imidazole alkaloids such as e.g. Isomacrorin or pilocarpine used.
  • the invention therefore relates to a process for the preparation of compounds of the formula I.
  • X 1 and X are each independently CO-OR2, CO-NR3R4 or CN, and
  • R 1 and R2 are each independently hydrogen
  • R and R each independently of one another alkyl 1 with 1-7
  • R 3 and R4 have the meaning given
  • the invention relates in particular to a process for the preparation of the compounds of the formula Ia, in which A is NR.
  • the invention furthermore relates to the use of the compounds of the formula I, in particular of the formula Ia, prepared by the process according to the invention, for the preparation of active pharmaceutical ingredients, in particular pilocarpine.
  • R 1 and R 2 are each independently of one another hydrogen, alkyl having 1-7 C atoms or carbocyclic radicals.
  • R 1 and / or R2 represent an alkyl radical, this can be straight-chain or branched. This means methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, i-propyl, 1- (or 2-) methyl propyl, tert.
  • R 1 and / or R2 represent a carbocyclic radical, this can be aromatic, cycloaliphatic or araliphatic. This means preferably phenyl, benzyl,
  • Cyclohexyl 1-indanyl, tetrahydronaphthyl (e.g. 1,2,3,4-tetrahydro-1-naphthyl), benzocycloheptyl (e.g. 5-benzocycloheptyl), 9,10-dihydro-9-anthracenyl, 9H-fluorene-9 -yl,
  • the carbocyclic radicals mentioned above can each be unsubstituted or substituted with 1 to 6 substituents selected from the group consisting of alkyl, alkoxy with 1-5 C atoms and halogen.
  • the group R 3R4N- preferably denotes an N, N-diethyl, N, N-diethyl, N, N-dipropyl, N, N-diisopropyl,
  • N N-dibutyl, N ⁇ N-diisobutyl, N, N-di-sec-butyl, N, N
  • Di- (o-, m- or p-tolyl) amino residue or a morpholino, piperidino or N-methylanilino residue Di- (o-, m- or p-tolyl) amino residue or a morpholino, piperidino or N-methylanilino residue.
  • anion Y is likewise not critical for the course of the reaction; it preferably means Cl ⁇ or Br ⁇ .
  • NR glycine or aminoacetonitrile derivatives
  • Ilb: A CH-X 2: succinic acid derivatives
  • can by known methods as described in the literature for example in standard works such as Houben-Weyl, Methods of Organic Chemistry, Georg-Thieme-Verlag, Stuttgart ) are, namely according to reaction conditions, as they are known and suitable for the reactions mentioned, are prepared. Use can also be made of variants which are known per se and are not mentioned here in detail.
  • the starting materials of the formula III are also known and can be prepared from cyanuric chloride and N, N-dialkylformamides.
  • the reaction of the methylene compound of formula II with the salt of formula III is preferably carried out in an inert solvent in the presence of a base.
  • Suitable bases are, depending on the CH acidity of the methylene compound used, for example alkali or alkaline earth metal hydroxides such as lithium, calcium, barium, sodium or potassium hydroxide, alkali metal carbonates such as sodium or potassium carbonate, alcoholates such as sodium methylate, sodium ethylate, lithium ethylate or potassium tert-butoxide, alkali metal amides such as potassium or sodium amide, or orga ⁇ African bases such as triethylamine, pyridine, 4-N, N-dimethylaminopyridine, lutidine, piperidine, morpholine, piperazine, collidine or quinoline, lithium diisopropylamide or lithium tetraethylpiperidide.
  • Suitable inert solvents are preferably ethers such as diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, tert-butyl methyl ether or dioxane and amides such as dimethylformamide, N, N-dimethylpropylene urea, dirthylacetamide or N-methylpyrrolidone, furthermore sulfoxides such as dimethyl sulfoxide or sulfones such as sulfolane Hydrocarbons such as pentane, hexane, cyclohexane, benzene or toluene.
  • ethers such as diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, tert-butyl methyl ether or dioxane
  • amides such as dimethylformamide, N, N-dimethylpropylene urea, dirthylacetamide or N-methylpyrrolidone
  • reaction temperatures are expediently between -78 ° C. and +150 ° C., preferably between +20 ° C. and +100 ° C., and the reaction times are between 1 and 48 hours, depending on the reactivity of the methyl compound used.
  • both the carboxylic acid esters of the formula I in which X 1 is CO-OR2 can be used as the carboxamides of the formula I in which X .1 is CO-NR 3R4 also arise.
  • the ratio of the resulting products can easily be controlled by a suitable choice of the reaction conditions.
  • non-enolizable carboxylic acid esters which are suitable for trapping the amines formed in the reaction from the salt of formula III.
  • non-enolizable carboxylic acid esters are the methyl or ethyl esters of the corresponding carboxylic acid, such as, for example, benzoic acid, phthalic or terephthalic acid, perfluoroalkyl acids, such as trifluoroacetic acid, or the aliphatic carboxylic acid, which has no hydrogen atoms ⁇ to the carboxyl group, such as eg pivalic acid or oxalic acid.
  • the carboxamides of the formula I in which X 1 or X1 and X2 is CO-NR3R4 can also be prepared in a targeted manner by the reaction without the addition of such
  • Y " ⁇ come inorganic acid residues such as F, Cl, Br, J, J_, HSO., H P0. Or CIO., But also organic acid residues such as carboxylates, especially acetate or trifluoroacetate, or sulfonates, especially p-toluenesulfonate, Trifluoromethanesulfonate or methanesulfonate, with chlorides being particularly preferred.
  • the 5-membered, nitrogen-containing heterocycles which can be prepared by the process according to the invention are also valuable starting materials for the production of dyes, crop protection agents and other pharmaceuticals or are themselves suitable, such as, for example, in EP-OS 0207563, as a means of influencing plant growth.
  • the process according to the invention thus allows the preparation of compounds of the formula I, in particular of the formula Ia, in a simple manner in high yields from easily accessible, inexpensive starting materials in a single synthesis step to be carried out in a one-pot process and thus represents a significant step forward in the process Field of synthesis of compounds of formula I, in particular in pilocarpine synthesis.
  • a suspension of 189.07 g of sodium methylate in 2000 ml of dioxane is initially introduced under nitrogen at room temperature, 181.45 g of sarcosine methyl ester hydrochloride and 261.84 g of 3-dimethylamino-2-azaprop-2- en-l-ylidene-dimethylammonium chloride and the reaction mixture is stirred at 60 ° C. for 24 hours.
  • a suspension of 54.03 g of sodium methylate in 600 ml of dioxane is introduced under nitrogen at room temperature, and 41.87 g of sarcosine methyl ester hydrochloride, 65.46 g of 3-dimethylamino-2-azaprop-2-ene 1- are carried in succession.
  • ylidene-dimethylammonium chloride and 47.24 g of dimethyl oxalate and the reaction mixture is stirred at 65 ° C. for 12 hours. It is then suctioned off through diatomaceous earth, washed with dioxane and concentrated under reduced pressure.
  • a suspension of 162 g of sodium methylate in 2000 ml of dioxane is initially introduced under nitrogen at room temperature, 139.6 g of sarcosine methyl ester hydrochloride and 212.7 g of 3-dimethylamino-2-azaprop-2-ene are carried in succession with stirring. l-ylidene-dimethylammonium chloride and the reaction mixture is stirred at 90 ° C. for 24 hours.
  • a mixture of 4.5 is added at -78 ° C. to a mixture of lithium diisopropylamide (made from 3.0 g of diisopropylamine and 19 ml of a 15% solution of n-butyllithium in hexane) and 15 ml of tetrahydrofuran, which is kept under nitrogen g of succinic acid dibenzyl ester and 10 ml of tetrahydrofuran. After warming up to 0 ° C., 3.1 g of 3-dimethylamino-2-azaprop-2-en-1-ylidene-dimethylammonium chloride are added and the mixture is stirred for 24 hours at boiling temperature.
  • Potassium hydride (4.15 g, 35% oil suspension) is washed twice with 15 ml of hexane and suspended in 150 ml of diethylene glycol.
  • 11.6 g of diethyl (cyan (1- (tert-butoxycarbonyl) propyl) methyl) phosphonate (prepared according to Ref.) are added to this mixture at 0 ° C.
  • a mixture of 4.0 g of 1-methyl-1H-imidazole-5-carboxaldehyde (prepared from 1-methyl-1H-imidazolecarboxylic acid methyl ester J according to Ref. 2) and 20 ml Add diethylene glycol and stir for 12 hours at room temperature.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

On peut préparer de manière simple, en grandes quantités et dans le même récipient des composés de la formule (I), dans laquelle A et X1 ont les significations décrites dans la première revendication.
EP89904057A 1988-04-07 1989-03-25 Procede de production d'heteroaromates azotes a 5 membres Pending EP0362350A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3811621 1988-04-07
DE3811621A DE3811621A1 (de) 1988-04-07 1988-04-07 Verfahren zur herstellung von 1h-imidazol-5-carbon-saeureestern oder -nitrilen und von pyrrol-3,4-carbonsaeureestern oder -nitrilen sowie verwendung der hergestellten verbindungen zur synthese von pilocarpin

Publications (1)

Publication Number Publication Date
EP0362350A1 true EP0362350A1 (fr) 1990-04-11

Family

ID=6351532

Family Applications (2)

Application Number Title Priority Date Filing Date
EP89904057A Pending EP0362350A1 (fr) 1988-04-07 1989-03-25 Procede de production d'heteroaromates azotes a 5 membres
EP89105365A Expired - Lifetime EP0336250B1 (fr) 1988-04-07 1989-03-25 Procédé de préparation de N-hétéro aromates à 5 chaînons

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP89105365A Expired - Lifetime EP0336250B1 (fr) 1988-04-07 1989-03-25 Procédé de préparation de N-hétéro aromates à 5 chaînons

Country Status (15)

Country Link
US (1) US5075452A (fr)
EP (2) EP0362350A1 (fr)
JP (2) JP2805230B2 (fr)
KR (1) KR0122131B1 (fr)
CN (1) CN1022920C (fr)
AT (1) ATE80388T1 (fr)
AU (1) AU616962B2 (fr)
CA (1) CA1338787C (fr)
DE (2) DE3811621A1 (fr)
ES (1) ES2052797T3 (fr)
HU (1) HU202214B (fr)
IE (1) IE63676B1 (fr)
IL (1) IL89860A0 (fr)
WO (1) WO1989009768A1 (fr)
ZA (1) ZA892516B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4033612A1 (de) * 1990-10-23 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von racemischen pilosinin-derivaten
JPH0641067A (ja) * 1992-04-20 1994-02-15 Kitasato Inst:The 新規カルパイン阻害物質ｋｐ−１２４１及びその製造法
GB9220068D0 (en) * 1992-09-23 1992-11-04 Smithkline Beecham Corp Process
US5565577A (en) * 1992-09-23 1996-10-15 Smithkline Beecham Corporation Process for preparing 1-alkyaryl-2-alkyl-5-formylimidazole
ATE207062T1 (de) * 1997-01-13 2001-11-15 Lonza Ag Verfahren zur herstellung von substituierten pyrimidinderivaten
CN1086189C (zh) * 1997-06-12 2002-06-12 食品机械和化工公司 超细微晶纤维素组合物及其制备方法
CN101397274B (zh) * 2008-10-22 2012-06-27 江苏先声药物研究有限公司 一种天然咪唑甲酸衍生物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1184709A (fr) * 1957-09-21 1959-07-24 Cfmc Nouveaux dérivés imidazoliques, utilisables comme agents de protection contre les rayons ultra-violets et leurs procédés de fabrication
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
JPS61178968A (ja) * 1985-12-13 1986-08-11 Nippon Carbide Ind Co Ltd １−置換イミダゾ−ル−５−カルボキサミド誘導体の製法
JP2562872B2 (ja) * 1986-01-25 1996-12-11 四国化成工業 株式会社 シアノ−イミダゾ−ル化合物の合成法
DE3729852A1 (de) * 1987-09-05 1989-03-23 Basf Ag Verfahren zur herstellung von 1-alkylimidazol-5-carbonsaeuren sowie deren estern, amiden und nitrilen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8909768A1 *

Also Published As

Publication number Publication date
EP0336250B1 (fr) 1992-09-09
AU3364289A (en) 1989-11-03
HU202214B (en) 1991-02-28
DE3811621A1 (de) 1989-10-26
CN1022920C (zh) 1993-12-01
HUT51258A (en) 1990-04-28
JP2805230B2 (ja) 1998-09-30
CN1037896A (zh) 1989-12-13
KR900700461A (ko) 1990-08-13
US5075452A (en) 1991-12-24
IL89860A0 (en) 1989-12-15
EP0336250A1 (fr) 1989-10-11
IE63676B1 (en) 1995-05-31
CA1338787C (fr) 1996-12-10
JP3226863B2 (ja) 2001-11-05
WO1989009768A1 (fr) 1989-10-19
AU616962B2 (en) 1991-11-14
JPH02504518A (ja) 1990-12-20
JPH10182637A (ja) 1998-07-07
ES2052797T3 (es) 1994-07-16
DE58902228D1 (de) 1992-10-15
ZA892516B (en) 1989-12-27
ATE80388T1 (de) 1992-09-15
KR0122131B1 (ko) 1997-11-13
HU892146D0 (en) 1990-02-28
IE891101L (en) 1989-10-07

Similar Documents

Publication Publication Date Title
EP0176846A2 (fr) Dérivés de l'acide amino-3-benzoyl-2-acrylique et procédé de leur préparation
EP0789019B1 (fr) Procédé pour la préparation de sels du 4-oxoimidazolinium
EP0336250B1 (fr) Procédé de préparation de N-hétéro aromates à 5 chaînons
EP0380712B1 (fr) Procédé de préparation de dérivés de l'acide 2,6-dichlorodiphénylaminoacétique
EP0234516B1 (fr) Dérivés de la 1,6-naphtyridine, procédé pour leur préparation et médicament les contenant pour le traitement des maladies cardio-vasculaires
EP1607090B1 (fr) Asimadoline pour le traitement du syndrome du colon irritable
EP0216324B1 (fr) Ester d'acides 4-alkoxy-3-pyrrolin-2-one-1-yl-acétiques et leur préparation
EP0252353B1 (fr) 4-Benzyloxy-3-pyrroline-2-one-1-yl-acétamide, préparation et utilisation
DE2220256C3 (de) N-(o- bzw. p-nitrobenzoyl)-sulfoximine, verfahren zu ihrer herstellung und verwendung derselben
DE69703115T2 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
EP0782991B1 (fr) Procédé pour la préparation de 5-chloroimidazole-4-carbaldéhydes substitués sur la position 2
DE1935404C3 (de) Verfahren zur Herstellung von Chinazoline nen
CH653996A5 (de) Tryptaminderivate und verfahren zu deren herstellung.
DD247217A5 (de) Verfahren zur herstellung von 2,6,-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarbonsaeure-3 beta (n-benzyl-n-methylamino)-ethylester-5-methylester und dessen hydrochlorid-salz
DE2661028C2 (fr)
DE3027619A1 (de) 6-alkyl-7-phenyl-1,6-naphtyradin- 5(6h)-on-derivate
EP0104566B1 (fr) Procédé pour la préparation de 5,11-dihydro-11-((4-méthyl-1-pipérazinyl)-acétyl)-6H-pyrido(2,3-b)(1,4)benzodiazépin-6-one
DE2653251A1 (de) Azabicyclo eckige klammer auf 3.1.o eckige klammer zu hexan-derivate, ihre herstellung und verwendung
DE2828888C2 (fr)
DE69711265T2 (de) Verfahren zur Herstellung von 5-(Alkoxymethyl)-2,3-Pyridindicarbonsäureimidverbindungen
DE19947953A1 (de) Verfahren zur selektiven Spaltung cyclischer Carbonsäureanhydride
EP0395580A2 (fr) Procédé pour la préparation de composés polycycliques
EP2554539B1 (fr) Procédé de fabrication de spirolactames gamma à partir d'acides carboniques cycliques insaturés
DE2628469B2 (de) Verfahren zur Herstellung von γ -Aminoalkoholen
DE3209081C2 (fr)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19900221

XX Miscellaneous (additional remarks)

Free format text: VERFAHREN ABGESCHLOSSEN INFOLGE VERBINDUNG MIT 89105365.4/0336250 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) VOM 06.08.91.